Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Myrmecia pilosula (jack jumper) ant venom: inter-laboratory validation study of a procedure to standardise an allergy vaccine

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: WANANDY, Stephanus Troy (Department of Pharmacy, Royal Hobart Hospital, Hobart, Tasmania, Australia)
  • Co-author(s): Turkanovic, Jasmina (Centre for Pharmaceutical Research, University of South Australia, Adelaide, SA, Australia)
    Marchant, Ceilidth (Centre for Pharmaceutical Research, University of South Australia, Adelaide, SA, Australia)
    Valentine, Jason (Centre for Pharmaceutical Research, University of South Australia, Adelaide, SA, Australia)
    Milne, Robert W. (Centre for Pharmaceutical Research, University of South Australia, Adelaide, SA, Australia)
    Brown, Simon G. A. (Department of Emergency Medicine, Royal Hobart Hospital, Tasmania, Australia)
    Wiese, Michael D. (Department of Pharmacy, Royal Hobart Hospital, HOBART, TASMANIA, Australia)
  • Abstract:

    Abstract: The ‘Jack Jumper’ ant (JJA, Myrmecia pilosula species complex) is a major cause of ant sting anaphylaxis in Australia.1 Recent work by the group has extended the findings of previous reports in an attempt to identify the causative agents of the allergic reactions.1 The group has used the knowledge to successfully develop a venom..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses